A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)

Clinical trial NCT02327078 · COMPLETED

Trial details

NCT number: NCT02327078
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-cell Malignancies Colorectal Cancer (CRC)Head and Neck Cancer Lung Cancer Lymphoma Melanoma Ovarian Cancer Glioblastoma

Start date: 2014-11-26
Primary completion: 2020-06-16
Enrollment: 307

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.